{"transactions":[{"id":2689859,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-01T16:07:31.000Z","date":"2021-05-27","kind":"exercise","acquired":false,"shares":36008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option fully vested on December 31, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period and a lock-up agreement period."}],"balance_after":0,"derivative":{"exercise_price":3.76,"expiration_date":"2021-05-28","underlying":"Common Shares","underlying_shares":36008},"source":{"system":"sec-edgar","filing":"0001209191-21-036798","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919121036798/doc4.xml","form_type":"4"}},{"id":2689858,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-01T16:07:31.000Z","date":"2021-05-27","kind":"exercise","acquired":false,"shares":3086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option fully vested on December 31, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period and a lock-up agreement period."}],"balance_after":0,"derivative":{"exercise_price":3.76,"expiration_date":"2021-05-28","underlying":"Common Shares","underlying_shares":3086},"source":{"system":"sec-edgar","filing":"0001209191-21-036798","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919121036798/doc4.xml","form_type":"4"}},{"id":2689857,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-06-01T16:07:31.000Z","date":"2021-05-27","kind":"sale","acquired":false,"shares":8485,"price":18.68,"value":158499.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $18.54 to $18.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein"}],"balance_after":143653,"source":{"system":"sec-edgar","filing":"0001209191-21-036798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919121036798/doc4.xml","form_type":"4"}},{"id":2689856,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-06-01T16:07:31.000Z","date":"2021-05-27","kind":"sale","acquired":false,"shares":2579,"price":18.69,"value":48201.51,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $18.51 to $18.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein"}],"balance_after":152138,"source":{"system":"sec-edgar","filing":"0001209191-21-036798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919121036798/doc4.xml","form_type":"4"}},{"id":2689855,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-06-01T16:07:31.000Z","date":"2021-05-27","kind":"tax_withholding","acquired":false,"shares":5911,"price":18.88,"value":111599.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of the Company's common shares on May 26, 2021, which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":154717,"source":{"system":"sec-edgar","filing":"0001209191-21-036798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919121036798/doc4.xml","form_type":"4"}},{"id":2689854,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-06-01T16:07:31.000Z","date":"2021-05-27","kind":"exercise","acquired":true,"shares":36008,"price":3.76,"value":135390.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":160628,"source":{"system":"sec-edgar","filing":"0001209191-21-036798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919121036798/doc4.xml","form_type":"4"}},{"id":2689853,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-06-01T16:07:31.000Z","date":"2021-05-27","kind":"tax_withholding","acquired":false,"shares":507,"price":18.88,"value":9572.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of the Company's common shares on May 26, 2021, which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":124620,"source":{"system":"sec-edgar","filing":"0001209191-21-036798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919121036798/doc4.xml","form_type":"4"}},{"id":2689852,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-06-01T16:07:31.000Z","date":"2021-05-27","kind":"exercise","acquired":true,"shares":3086,"price":3.76,"value":11603.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":125127,"source":{"system":"sec-edgar","filing":"0001209191-21-036798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919121036798/doc4.xml","form_type":"4"}},{"id":3127860,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T16:54:35.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to\nthe Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year\nanniversary of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":13.11,"expiration_date":"2030-05-31","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-033588","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919120033588/doc4.xml","form_type":"4"}},{"id":3127859,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T16:54:35.000Z","date":"2020-05-29","kind":"exercise","acquired":false,"shares":3086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option fully vested on December 31, 2012. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period."}],"balance_after":0,"derivative":{"exercise_price":3.56,"expiration_date":"2020-06-02","underlying":"Common Shares","underlying_shares":3086},"source":{"system":"sec-edgar","filing":"0001209191-20-033588","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919120033588/doc4.xml","form_type":"4"}},{"id":3127858,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-06-02T16:54:35.000Z","date":"2020-05-29","kind":"exercise","acquired":true,"shares":3086,"price":3.56,"value":10986.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise"}],"balance_after":122041,"source":{"system":"sec-edgar","filing":"0001209191-20-033588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919120033588/doc4.xml","form_type":"4"}},{"id":3409258,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-09-20T16:15:21.000Z","date":"2019-09-20","kind":"sale","acquired":false,"shares":5206,"price":9.39,"value":48884.34,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $9.33 to $9.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein"}],"balance_after":118955,"source":{"system":"sec-edgar","filing":"0001209191-19-050318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919119050318/doc4.xml","form_type":"4"}},{"id":3409257,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-09-20T16:15:21.000Z","date":"2019-09-19","kind":"sale","acquired":false,"shares":7600,"price":9.27,"value":70452.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $9.25 to $9.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein"}],"balance_after":124161,"source":{"system":"sec-edgar","filing":"0001209191-19-050318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919119050318/doc4.xml","form_type":"4"}},{"id":3411303,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-18T18:43:09.000Z","date":"2019-09-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":9.44,"expiration_date":"2029-09-15","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-050136","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919119050136/doc4.xml","form_type":"4"}},{"id":3411302,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-09-18T18:43:09.000Z","date":"2019-09-18","kind":"sale","acquired":false,"shares":4368,"price":9.28,"value":40535.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $9.25 to $9.35, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":131761,"source":{"system":"sec-edgar","filing":"0001209191-19-050136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919119050136/doc4.xml","form_type":"4"}},{"id":3411301,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-09-18T18:43:09.000Z","date":"2019-09-17","kind":"sale","acquired":false,"shares":5069,"price":9.32,"value":47243.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $9.30 to $9.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":136129,"source":{"system":"sec-edgar","filing":"0001209191-19-050136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919119050136/doc4.xml","form_type":"4"}},{"id":3415327,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-13T20:13:31.000Z","date":"2019-09-12","kind":"exercise","acquired":false,"shares":25720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option fully vested February 1, 2012. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3,"expiration_date":"2019-09-18","underlying":"Common Shares","underlying_shares":25720},"source":{"system":"sec-edgar","filing":"0001209191-19-049550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919119049550/doc4.xml","form_type":"4"}},{"id":3415326,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-13T20:13:31.000Z","date":"2019-09-12","kind":"exercise","acquired":false,"shares":3086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option fully vested on December 31, 2011. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3.07,"expiration_date":"2019-09-18","underlying":"Common Shares","underlying_shares":3086},"source":{"system":"sec-edgar","filing":"0001209191-19-049550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919119049550/doc4.xml","form_type":"4"}},{"id":3415325,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-13T20:13:31.000Z","date":"2019-09-12","kind":"exercise","acquired":false,"shares":3086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option fully vested on May 31, 2011. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3.7,"expiration_date":"2019-09-18","underlying":"Common Shares","underlying_shares":3086},"source":{"system":"sec-edgar","filing":"0001209191-19-049550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919119049550/doc4.xml","form_type":"4"}},{"id":3415324,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-09-13T20:13:31.000Z","date":"2019-09-12","kind":"tax_withholding","acquired":false,"shares":7781,"price":9.38,"value":72985.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of the Company's common shares on September 11, 2019, which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":141198,"source":{"system":"sec-edgar","filing":"0001209191-19-049550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919119049550/doc4.xml","form_type":"4"}},{"id":3415323,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-09-13T20:13:31.000Z","date":"2019-09-12","kind":"exercise","acquired":true,"shares":25720,"price":3,"value":77160.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."}],"balance_after":148979,"source":{"system":"sec-edgar","filing":"0001209191-19-049550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919119049550/doc4.xml","form_type":"4"}},{"id":3415322,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-09-13T20:13:31.000Z","date":"2019-09-12","kind":"tax_withholding","acquired":false,"shares":934,"price":9.38,"value":8760.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of the Company's common shares on September 11, 2019, which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":123259,"source":{"system":"sec-edgar","filing":"0001209191-19-049550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919119049550/doc4.xml","form_type":"4"}},{"id":3415321,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-09-13T20:13:31.000Z","date":"2019-09-12","kind":"exercise","acquired":true,"shares":3086,"price":3.07,"value":9474.02,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."}],"balance_after":124193,"source":{"system":"sec-edgar","filing":"0001209191-19-049550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919119049550/doc4.xml","form_type":"4"}},{"id":3415320,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-09-13T20:13:31.000Z","date":"2019-09-12","kind":"tax_withholding","acquired":false,"shares":934,"price":9.38,"value":8760.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of the Company's common shares on September 11, 2019, which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":121107,"source":{"system":"sec-edgar","filing":"0001209191-19-049550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919119049550/doc4.xml","form_type":"4"}},{"id":3415319,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-09-13T20:13:31.000Z","date":"2019-09-12","kind":"exercise","acquired":true,"shares":3086,"price":3.7,"value":11418.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."}],"balance_after":122041,"source":{"system":"sec-edgar","filing":"0001209191-19-049550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938801/000120919119049550/doc4.xml","form_type":"4"}},{"id":3906559,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-05T16:40:39.000Z","date":"2018-06-04","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, and the balance of the total shares subject to the Option shall vest on the three year anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":6.2,"expiration_date":"2028-06-03","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001171843-18-004457","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938801/000117184318004457/formfour.xml","form_type":"4"}},{"id":3993455,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-16T16:23:45.000Z","date":"2018-03-14","kind":"exercise","acquired":false,"shares":3086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option fully vested on December 31, 2011.  The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3.77,"expiration_date":"2018-03-16","underlying":"Common Shares","underlying_shares":3086},"source":{"system":"sec-edgar","filing":"0001171843-18-002044","document":"formfourholler.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938801/000117184318002044/formfourholler.xml","form_type":"4"}},{"id":3993454,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2018-03-16T16:23:45.000Z","date":"2018-03-14","kind":"exercise","acquired":true,"shares":3086,"price":3.77,"value":11634.22,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."}],"balance_after":118955,"source":{"system":"sec-edgar","filing":"0001171843-18-002044","document":"formfourholler.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938801/000117184318002044/formfourholler.xml","form_type":"4"}},{"id":4296720,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-02T16:53:47.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, and the balance of the total shares subject to the Option shall vest on the three year anniversary of the grant date."}],"balance_after":3500,"derivative":{"exercise_price":3.85,"expiration_date":"2027-05-31","underlying":"Common Shares","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001171843-17-003441","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938801/000117184317003441/formfour.xml","form_type":"4"}},{"id":4517458,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":138864,"kind":"person","name":"HOLLER FRANK A","position":1,"cik":"0000938801","reported_name":"HOLLER FRANK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2016-12-19T17:07:49.000Z","date":"2016-12-15","kind":"sale","acquired":false,"shares":30000,"price":7.85,"value":235500.0,"ownership":{"direct":true},"balance_after":115869,"source":{"system":"sec-edgar","filing":"0001171843-16-013706","document":"f4_holler121916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938801/000117184316013706/f4_holler121916.xml","form_type":"4"}}]}